As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of all financial relationships with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All persons who influenced the content of this activity are required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed these disclosures and mitigated or managed all identified conflicts of interest through a peer review process.
The following faculty, reviewers and ASNC staff who were involved in the planning and development of this activity reported no financial relationships:
Renée Bullock-Palmer, MD (Education Reviewer)
Linda Giering, PhD (ASNC Staff)
Dawn Edgerton (ASNC Staff)
Faculty who were involved in the planning and development of this activity reported the following financial relationships:
Mouaz Al-Mallah, MD, MSc, MASNC - Research Grants (Siemens; GE Healthcare); Consultant (Jubilant Radiopharma; MedTrace; Phillips; Pfizer)
Panithaya Chareonthaitawee, MD - Consultant (GE Healthcare); Royalties (UpToDate)
Marcelo Di Carli, MD, MASNC - Research Grants (Amgen (institutional); Gilead Sciences); Consultant (Bitterroot Bio; IBA; MedTrace; Sanofi; Sun Pharma; Valo Health)
Jamshid Maddahi, MD, MASNC - Consultant (GE Healthcare); Principal Investigator Flupiridaz Trials/Research Funding (GE Healthcare)
Piotr Slomka, PhD, MASNC - Software Royalties (Cedars-Sinai); Consultant (Synektik)
Technical Advisor:
Jennifer Renaud, PhD - Employee (INVIA, LLC); Consultant (Jubilant Radiopharma)